1-20 of 60
Yasodha Natkunam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unraveling the Transcriptional Landscape of Nodular Lymphocyte-Predominant Hodgkin Lymphoma and T-Cell/Histiocyte Rich Large B-Cell Lymphoma: Impact of Tumor Microenvironment and Checkpoint Gene Expression

Ilja Kalashnikov, Veronica Russell, Panu Kovanen, Johannes Dunkel, Marja-Liisa Karjalainen-Lindsberg, Annika Pasanen, Rachel Kositsky, Sarah L. Ondrejka, Tanu Goyal, Eric D. Hsi, Mette Ølgod Pedersen, Anne Ortved Gang, Magdalena Czader, Jiehao Zhou, Mina Xu, Nathan Paulson, Jean L. Koff, Andrew G Evans, Yasodha Natkunam, Ridas Juskevicius, Abner Louissaint, Elizabeth Thacker, Tushar Dave, Cassandra L. Love, Chad M McCall, Choon Kiat Ong, Michael Churnetski, Haley Martin, Jennifer R. Chapman-Fredricks, Javeed Iqbal, Amy Chadburn, Payal Sojitra, Amir Behdad, William Choi, Jie Xu, Emily F. Ferguson Mason, Kikkeri N Naresh, Yuri D. Fedoriw, Dina Sameh Soliman, Sandeep Dave, Sirpa Leppä
Journal: Blood
Blood (2023) 142 (Supplement 1): 176.
https://doi.org/10.1182/blood-2023-182294
Published: 2023
Journal Articles

Investigating the Cell States and Prognostic Impact of Tumor Microenvironment Ecosystems in Classic Hodgkin Lymphoma

Shengqin Su, Ajay Subramanian, Timothy Flerlage, Jamie E. Flerlage, Stefan K. Alig, Everett J. Moding, Richard T. Hoppe, Ranjana H. Advani, Yasodha Natkunam, Ash A. Alizadeh, Michael S. Binkley
Journal: Blood
Blood (2023) 142 (Supplement 1): 3016.
https://doi.org/10.1182/blood-2023-180288
Published: 2023
Journal Articles

Results from an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Research Group (E4412)

Catherine S Diefenbach, Opeyemi Jegede, Stephen M Ansell, Christian Steidl, Yasodha Natkunam, David W. Scott, Neha Mehta-Shah, Jennifer E Amengual, Christopher J. Forlenza, Peter D. Cole, Nancy L. Bartlett, Kevin A. David, Ranjana H. Advani, Richard F. Ambinder, Sachdev Thomas, Sami Ibrahimi, Brad S. Kahl
Journal: Blood
Blood (2023) 142 (Supplement 1): 607.
https://doi.org/10.1182/blood-2023-184531
Published: 2023
Journal Articles

Determinants of Resistance to Engineered T-Cell Therapies Targeting CD19 in Large B-Cell Lymphomas

Brian Sworder, David M. Kurtz, Stefan K. Alig, Matthew J Frank, Navika D. Shukla, Andrea Garofalo, Charles Macaulay, Mohammad Shahrokh Esfahani, Mari Olsen, James Hamilton, III, Hitomi Hosoya, Mark P Hamilton, Jay Y. Spiegel, John H. Baird, Mia Carleton, Alexander F.M. Craig, Sheren F. Younes, Bita Sahaf, Natasha Sheybani, Joseph Schroers-Martin, Chih Long Liu, Jean S Oak, Michael C. Jin, Sara Beygi, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Jason Westin, Michael S. Khodadoust, Yasodha Natkunam, Robbie G. Majzner, Crystal L. Mackall, Maximilian Diehn, David B. Miklos, Ash A. Alizadeh
Journal: Blood
Blood (2022) 140 (Supplement 1): 1301–1303.
https://doi.org/10.1182/blood-2022-165545
Published: 2022
Journal Articles

Accurate Detection of Clinically Actionable Copy Number Variants in Diverse Hematological Neoplasms By Routine Targeted Sequencing: A Comparative Performance Study

Alicia Palomino Mosquera, Hitomi Hosoya, Michael C. Jin, Mohammad Shahrokh Esfahani, Joseph Schroers-Martin, Brian Sworder, Chih Long Liu, Elizabeth Spiteri, Yasodha Natkunam, James L Zehnder, Henning Stehr, David M. Kurtz, Ash A. Alizadeh
Journal: Blood
Blood (2022) 140 (Supplement 1): 10712–10713.
https://doi.org/10.1182/blood-2022-167900
Published: 2022
Journal Articles

Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders

Joseph Schroers-Martin, Andrea Garofalo, Joanne Soo, Jan Boegeholz, Stefan K. Alig, Brian Sworder, Chih Long Liu, Helen Luikart, Gerardo Gamino, DP Morales, Kathrin Freystätter, James Hamilton, III, David M. Kurtz, Seth Hollander, David Rosenthal, Gundeep Dhillon, Jayant Raikhelkar, Stijn Verleden, Marcel Nijland, Sean Agbor-Enoh, Martin Andreas, Abdallah Kfoury, Heather Ross, Lorenzo Zaffiri, Yasodha Natkunam, Maximilian Diehn, Kiran Khush, Ash A. Alizadeh
Journal: Blood
Blood (2022) 140 (Supplement 1): 172–174.
https://doi.org/10.1182/blood-2022-158647
Published: 2022
Journal Articles

Nodular Lymphocyte Predominant Hodgkin Lymphoma with Splenic Involvement Is Characterized By Inflamed Tumor Microenvironment, High Expression of Checkpoint Molecule Gene-Signature and Adverse Outcome

Ilja Kalashnikov, Marja-Liisa Karjalainen-Lindsberg, Panu Kovanen, Johannes Dunkel, Annika Pasanen, Rachel Kositsky, Sarah L. Ondrejka, Eric D. Hsi, Andrew G Evans, Mette Ø Pedersen, Peter H. Norgaard, Anne Ortved Gang, Magdalena Czader, Jiehao Zhou, Mina L Xu, Nathan Paulson, Ridas Juskevicius, Yasodha Natkunam, Abner Louissaint, Jr., Haley Martin, Elizabeth Thacker, Cassandra Love, Shari Tian, Choon Kiat Ong, Chee Leong Cheng, Chad M. McCall, Jean L. Koff, Sheren F. Younes, Mary Ann Arildsen, Jennifer R Chapman-Fredricks, Catalina Amador, Yuri Fedoriw, Carla Casulo, Amy Chadburn, Payal Sojitra, Amir Behdad, Eric Tse, Kikkeri N Naresh, C. Cameron Yin, Rashmi S. Goswami, Sandeep Dave, Sirpa Leppa
Journal: Blood
Blood (2022) 140 (Supplement 1): 3559–3561.
https://doi.org/10.1182/blood-2022-169476
Published: 2022
Journal Articles

Tumor-Confirmed Follicular Lymphoma Mutations Are Detectable in Peripheral Blood Years Prior to Clinical Diagnosis

Joseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, Florian Scherer, David M. Kurtz, Brian Sworder, Michael S. Khodadoust, Michael C. Jin, Agnès Bru, Chih Long Liu, Henning Stehr, Paolo Vineis, Yasodha Natkunam, Lauren R Teras, Joo Y. Song, Bertrand Nadel, Maximilian Diehn, Sandrine Roulland, Ash A. Alizadeh
Journal: Blood
Blood (2021) 138 (Supplement 1): 709.
https://doi.org/10.1182/blood-2021-151058
Published: 2021
Journal Articles

The Atlas of Blood Cancer Genomes (ABCG) Project: A Comprehensive Molecular Characterization of Leukemias and Lymphomas

Cassandra Love, Raju Pillai, Sarah L. Ondrejka, Govind Bhagat, Amy Chadburn, Matthew McKinney, Jean L. Koff, Dina Sameh Soliman, Magdalena Czader, Abner Louissaint, Jr., Shaoying Li, Choon Kiat Ong, Amir Behdad, Andrew M. Evens, Yasodha Natkunam, Peter H. Norgaard, Sirpa Leppa, Eric Tse, Jennifer R Chapman, Catalina Amador, Yuri Fedoriw, Agata M. Bogusz, Andrew G Evans, Rashmi S. Goswami, Ridas Juskevicius, Mina L. Xu, Kikkeri N Naresh, Barbara Xiong, Adam Snowden, Anabel Thurman, Eileen Smith, Tushar Dave, Rachel Kositsky, Devang Thakkar, Veronica Russell, Caroline J Roth, Sandeep Dave
Journal: Blood
Blood (2021) 138 (Supplement 1): 2213.
https://doi.org/10.1182/blood-2021-151346
Published: 2021
Journal Articles

CD22-CAR T-Cell Therapy Mediates High Durable Remission Rates in Adults with Large B-Cell Lymphoma Who Have Relapsed after CD19-CAR T-Cell Therapy

Matthew J. Frank, John H. Baird, Shabnum Patel, Juliana Craig, Jay Y. Spiegel, Zachary Ehlinger, Harshini Chinnasamy, Sheren F. Younes, Jean S. Oak, Yasodha Natkunam, Warren D. Reynolds, Maria Iglesias, Emma Crawford, Hrishikesh K. Srinagesh, Emily L. Egeler, Sally Arai, Laura J. Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen-Kai Weng, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Bita Sahaf, Steven A. Feldman, Crystal L. Mackall, David B. Miklos, Lori Muffly
Journal: Blood
Blood (2021) 138 (Supplement 1): 741.
https://doi.org/10.1182/blood-2021-152145
Published: 2021
Journal Articles

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

Clinical Trials & Observations Brief Report
John H. Baird, Matthew J. Frank, Juliana Craig, Shabnum Patel, Jay Y. Spiegel, Bita Sahaf, Jean S. Oak, Sheren F. Younes, Michael G. Ozawa, Eric Yang, Yasodha Natkunam, John Tamaresis, Zachary Ehlinger, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen-Kai Weng, Kara L. Davis, Sneha Ramakrishna, Liora Schultz, Chelsea Mullins, Allison Jacob, Ilan Kirsch, Steven A. Feldman, Crystal L. Mackall, David B. Miklos, Lori Muffly
Journal: Blood
Blood (2021) 137 (17): 2321–2325.
https://doi.org/10.1182/blood.2020009432
Published: 2021
Includes: Supplemental data
Journal Articles

Elusive sentinels at the Hodgkin checkpoint

Sheren Younes, Yasodha Natkunam
Journal: Blood
Blood (2020) 136 (25): 2841–2842.
https://doi.org/10.1182/blood.2020009463
Published: 2020
Journal Articles

CD22-Directed CAR T-Cell Therapy Mediates Durable Complete Responses in Adults with Relapsed or Refractory Large B-Cell Lymphoma after Failure of CD19-Directed CAR T-Cell Therapy and High Response Rates in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

John H. Baird, MD, Matthew J. Frank, MD PhD, Juliana Craig, BA, Shabnum Patel, PhD, Jay Y. Spiegel, MDFRCPC, Bita Sahaf, PhD, Sheren F. Younes, MD PhD, Jean S. Oak, MD PhD, Yasodha Natkunam, MD PhD, Zachary Ehlinger, MS, Warren D. Reynolds, BS, Sally Arai, MD MS, Laura J. Johnston, MD, Robert Lowsky, MD FRCP, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Parveen Shiraz, MD, Surbhi Sidana, MD, Wen-Kai Weng, MD PhD, Liora M. Schultz, MD, Sneha Ramakrishna, MD, Kara L Davis, DO, Steven A. Feldman, PhD, Crystal L. Mackall, MD, David B. Miklos, MD PhD, Lori S. Muffly, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-139087
Published: 2020
Journal Articles

Recurrent Crebbp Mutations in Follicular Lymphoma Appear Localized to the Committed B-Cell Lineage

Joseph G Schroers-Martin, MD, Joanne Soo, MD, Gabriel Brisou, MD, Florian Scherer, MD, David M. Kurtz, MDPhD, Brian Sworder, MD PhD, Michael S. Khodadoust, MD PhD, Michael C. Jin, BS, Agnès Bru, Chih Long Liu, PhD, Henning Stehr, PhD, Paolo Vineis, PhD, Yasodha Natkunam, MD PhD, Bertrand Nadel, PhD, Maximilian Diehn, MD PhD, Sandrine Roulland, PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-142761
Published: 2020
Journal Articles

CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering

Robbie G. Majzner, MD, Matthew J. Frank, MD PhD, Christopher Mount, MD PhD, Aidan Tousley, David M. Kurtz, MDPhD, Brian Sworder, MD PhD, Katherine A Murphy, Antigoni Manousopoulou, Kennedy Kohler, Maria Caterina Rotiroti, PhD, Jay Y. Spiegel, MDFRCPC, Yasodha Natkunam, MD PhD, Sheren F. Younes, MD PhD, Elena Sotillo, PhD, Vandon Duong, Charles Macaulay, MSc, BA, Zinaida Good, PhD, Peng Xu, MD, Louai Labanieh, Leo D Wang, MD PhD, Ash A. Alizadeh, MD PhD, Michelle Monje, MD PhD, David B. Miklos, MD PhD, Crystal L. Mackall, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53–54.
https://doi.org/10.1182/blood-2020-139605
Published: 2020
Journal Articles

Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG

Clinical Trials & Observations
Michael S. Binkley, M. Shahzad Rauf, Sarah A. Milgrom, Chelsea C. Pinnix, Richard Tsang, Michael Dickinson, Andrea K. Ng, Kenneth B. Roberts, Sarah Gao, Alex Balogh, Umberto Ricardi, Mario Levis, Carla Casulo, Michael Stolten, Lena Specht, John P. Plastaras, Christopher Wright, Christopher R. Kelsey, Jessica L. Brady, N. George Mikhaeel, Bradford S. Hoppe, Stephanie A. Terezakis, Marco Picardi, Roberta Della Pepa, Youlia Kirova, Saad Akhtar, Irfan Maghfoor, Julie L. Koenig, Christopher Jackson, Erin Song, Shuchi Sehgal, Ranjana H. Advani, Yasodha Natkunam, Louis S. Constine, Hans T. Eich, Andrew Wirth, Richard T. Hoppe
Journal: Blood
Blood (2020) 135 (26): 2365–2374.
https://doi.org/10.1182/blood.2019003877
Published: 2020
Includes: Supplemental data
Journal Articles

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Chloe B. Steen, MSc, Bogdan A. Luca, PhD, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, PhD, Brian Sworder, MD PhD, Farshad Farshidfar, MD PhD, Kiarash Shamardani, BA, David M. Kurtz, MD PhD, Chih Long Liu, PhD, Ranjana H Advani, MD, Yasodha Natkunam, MD PhD, June Helen Myklebust, PhD, Maximilian Diehn, MD PhD, Andrew Gentles, PhD, Aaron M Newman, PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 655.
https://doi.org/10.1182/blood-2019-129461
Published: 2019
Journal Articles

High Accuracy, Low-Cost Transcriptional Diagnostic to Transform Lymphoma Care in Low- and Middle-Income Countries

Edward Briercheck, MD, Fabiola Valvert, MD, Elizabeth Solorzano, MSc, Oscar Silva, MD PhD, Maneka Puligandla, MS, Marcos Mauricio Siliézar Tala, MD, Timothy Guyon, MSc, Samuel L. Dixon, BS, Robert Terbrueggen, PhD, Yasodha Natkunam, MD PhD, Kristen E. Stevenson, MS, David M Weinstock
Journal: Blood
Blood (2019) 134 (Supplement_1): 409.
https://doi.org/10.1182/blood-2019-121397
Published: 2019
Journal Articles

A Clinically-Indolent Variant of Extranodal NK/T Cell Lymphoma with Unique Immunophenotypic Profile and Superior Outcome

Fabiola Valvert, MD, Elizabeth Solorzano, MSc, Edward Briercheck, MD, Marcos Mauricio Siliézar Tala, MD, Yasodha Natkunam, MD PhD, David M. Weinstock, MD, Oscar Silva, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5278.
https://doi.org/10.1182/blood-2019-131620
Published: 2019
Journal Articles

Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies

Andrea Garofalo, BS, BA, Joseph G Schroers-Martin, MD, Joanne Soo, MD, David M. Kurtz, MD PhD, Brian Sworder, MD PhD, Chih Long Liu, PhD, Benjamin A Pinsky, MD PhD, Helen Luikart, RN, MSN, Ranjana H Advani, MD, Yasodha Natkunam, MD PhD, Kiran Khush, MD, Maximilian Diehn, MD PhD, Arash A. Alizadeh, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 885.
https://doi.org/10.1182/blood-2019-131602
Published: 2019